Well, none of our 'experts' have extended the courtesy of attempting to answer any of my poorly worded or confusing inquires/questions posted last night, #34694, so I'll try again, I guess and hope someone knowledgeable will respond.
Rabin talks about a 'global settlement for the lawsuits.
As best as I can see we're looking at only 4 currently that have materialized.
Reference has been made to similar financing language in 50 prior situations, so does this mean we can expect possibly many more lawsuits, hence the term 'global settlement, to be prepared for more settlements, possibly through some kind of court established fund (I'm not an attorney)?
It clearly seems we need more shares to be issued soon. How long does that sort of thing take and could that be tied into the cc in a few weeks?
If Rabin has repeatedly said we have enough cash to move forward with funding our human clinicals, does that suggest then that a buy out would be silly and put ACTC in a premature position of giving away too much and operating out of weakness, therefore forge about a buy out happening?
If continuing clinical data remains positive, does this then pave the way for the likelihood of a 2012 joint venture sometime being more realistic, after all there remains a continuing need for cash to fund all sorts of ongoing expenses?
Thanks.
AI
